Assistant Professor, Medicine-Brigham and Women's Hospital, Harvard Medical School
Internal Medicine
Dr. Mark M. Pomerantz, MD
|
|
Give Review
Mark M. Pomerantz, MD works in the field of Internal Medicine. He attended Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine Mark Pomerantz has written publications. He has 21 publications published with PubMed. The lastest paper is: 'Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.' Mark Pomerantz accepts Medicare.
Publications
- CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
- The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
- Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
- Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
- Sequencing current therapies in the treatment of metastatic prostate cancer.
- Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared with Gleason 8 Disease.
- Clinical predictors of survival in men with castration-resistant prostate cancer: Evidence That Gleason Score 6 Cancer Can Evolve to Lethal Disease.
- Clinical uncertainty of prostate cancer genetic risk panels.
- Renal-cell carcinoma: a step closer to a new classification.
- Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
- Moving toward personalized medicine in castration-resistant prostate cancer.
- The Role of Genetic Markers in the Management of Prostate Cancer.
- The genetics of cancer risk.
- Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
- Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
- Genetics of prostate cancer risk.
- 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
- Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
- Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen...
Schools
Stanford University School Of Medicine
Conditions Treated
- Anemia
- Deep Vein Thrombosis (DVT)
- Leukocytosis
- Myelodysplastic Syndromes
- View All
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Stanford University School of Medicine
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1194701599 | |
| NPPES Provider LastName | POMERANTZ | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 021142696 | |
| NPPES Provider State | MA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 169.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194701599 |
| Last Name Of The Provider | POMERANTZ |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Srivatsan Raghavan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wasif M. Abidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Harmon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Kuter, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Zachary P. Fricker, MD |
|
|
Dr. Claude I. Alabre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Martinez, MD |
|
|
Dr. Diana E. Post, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Magali N. Tshiamala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaine S. Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cy R. Wilkins, MD
This Doctor is OpenDoctor Recommended.
|